Cargando…

Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis

BACKGROUND: At present, large-scale use of two malaria vector control methods, long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) is being scaled up in Africa with substantial funding from donors. A third vector control method, larval source management (LSM), has been historic...

Descripción completa

Detalles Bibliográficos
Autores principales: Worrall, Eve, Fillinger, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233614/
https://www.ncbi.nlm.nih.gov/pubmed/22067606
http://dx.doi.org/10.1186/1475-2875-10-338
_version_ 1782218444286984192
author Worrall, Eve
Fillinger, Ulrike
author_facet Worrall, Eve
Fillinger, Ulrike
author_sort Worrall, Eve
collection PubMed
description BACKGROUND: At present, large-scale use of two malaria vector control methods, long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) is being scaled up in Africa with substantial funding from donors. A third vector control method, larval source management (LSM), has been historically very successful and is today widely used for mosquito control globally, except in Africa. With increasing risk of insecticide resistance and a shift to more exophilic vectors, LSM is now under re-evaluation for use against afro-tropical vector species. Here the costs of this intervention were evaluated. METHODS: The 'ingredients approach' was used to estimate the economic and financial costs per person protected per year (pppy) for large-scale LSM using microbial larvicides in three ecologically diverse settings: (1) the coastal metropolitan area of Dar es Salaam in Tanzania, (2) a highly populated Kenyan highland area (Vihiga District), and (3) a lakeside setting in rural western Kenya (Mbita Division). Two scenarios were examined to investigate the cost implications of using alternative product formulations. Sensitivity analyses on product prices were carried out. RESULTS: The results show that for programmes using the same granular formulation larviciding costs the least pppy in Dar es Salaam (US$0.94), approximately 60% more in Vihiga District (US$1.50) and the most in Mbita Division (US$2.50). However, these costs are reduced substantially if an alternative water-dispensable formulation is used; in Vihiga, this would reduce costs to US$0.79 and, in Mbita Division, to US$1.94. Larvicide and staff salary costs each accounted for approximately a third of the total economic costs per year. The cost pppy depends mainly on: (1) the type of formulation required for treating different aquatic habitats, (2) the human population density relative to the density of aquatic habitats and (3) the potential to target the intervention in space and/or time. CONCLUSION: Costs for LSM compare favourably with costs for IRS and LLINs, especially in areas with moderate and focal malaria transmission where mosquito larval habitats are accessible and well defined. LSM presents an attractive tool to be integrated in ongoing malaria control effort in such settings. Further data on the epidemiological health impact of larviciding is required to establish cost effectiveness.
format Online
Article
Text
id pubmed-3233614
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32336142011-12-08 Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis Worrall, Eve Fillinger, Ulrike Malar J Research BACKGROUND: At present, large-scale use of two malaria vector control methods, long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) is being scaled up in Africa with substantial funding from donors. A third vector control method, larval source management (LSM), has been historically very successful and is today widely used for mosquito control globally, except in Africa. With increasing risk of insecticide resistance and a shift to more exophilic vectors, LSM is now under re-evaluation for use against afro-tropical vector species. Here the costs of this intervention were evaluated. METHODS: The 'ingredients approach' was used to estimate the economic and financial costs per person protected per year (pppy) for large-scale LSM using microbial larvicides in three ecologically diverse settings: (1) the coastal metropolitan area of Dar es Salaam in Tanzania, (2) a highly populated Kenyan highland area (Vihiga District), and (3) a lakeside setting in rural western Kenya (Mbita Division). Two scenarios were examined to investigate the cost implications of using alternative product formulations. Sensitivity analyses on product prices were carried out. RESULTS: The results show that for programmes using the same granular formulation larviciding costs the least pppy in Dar es Salaam (US$0.94), approximately 60% more in Vihiga District (US$1.50) and the most in Mbita Division (US$2.50). However, these costs are reduced substantially if an alternative water-dispensable formulation is used; in Vihiga, this would reduce costs to US$0.79 and, in Mbita Division, to US$1.94. Larvicide and staff salary costs each accounted for approximately a third of the total economic costs per year. The cost pppy depends mainly on: (1) the type of formulation required for treating different aquatic habitats, (2) the human population density relative to the density of aquatic habitats and (3) the potential to target the intervention in space and/or time. CONCLUSION: Costs for LSM compare favourably with costs for IRS and LLINs, especially in areas with moderate and focal malaria transmission where mosquito larval habitats are accessible and well defined. LSM presents an attractive tool to be integrated in ongoing malaria control effort in such settings. Further data on the epidemiological health impact of larviciding is required to establish cost effectiveness. BioMed Central 2011-11-08 /pmc/articles/PMC3233614/ /pubmed/22067606 http://dx.doi.org/10.1186/1475-2875-10-338 Text en Copyright ©2011 Worrall and Fillinger; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Worrall, Eve
Fillinger, Ulrike
Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis
title Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis
title_full Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis
title_fullStr Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis
title_full_unstemmed Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis
title_short Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis
title_sort large-scale use of mosquito larval source management for malaria control in africa: a cost analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233614/
https://www.ncbi.nlm.nih.gov/pubmed/22067606
http://dx.doi.org/10.1186/1475-2875-10-338
work_keys_str_mv AT worralleve largescaleuseofmosquitolarvalsourcemanagementformalariacontrolinafricaacostanalysis
AT fillingerulrike largescaleuseofmosquitolarvalsourcemanagementformalariacontrolinafricaacostanalysis